Key Takeaways in Relapsed and Refractory Multiple Myeloma

In this final segment, Dr. Ajay Nooka invites Dr. Noopur Raje and Dr. Surbhi Sidana to share key takeaways from their discussion on relapsed and refractory multiple myeloma. The panel reflects on the evolving treatment landscape and emphasizes the importance of individualized care, informed by disease characteristics, prior therapy exposure, and patient-specific factors. They highlight the growing complexity of treatment selection and the need for thoughtful sequencing across available therapeutic classes. The discussion also underscores the importance of early planning, multidisciplinary collaboration, and proactive management of toxicity and access-related challenges. Looking ahead, the panel identifies opportunities to improve patient outcomes through continued research, optimized care coordination, and integration of emerging evidence into clinical practice. This segment provides a concise summary of practical insights for clinicians managing multiple myeloma in real-world settings.